Potential Anti-allergic Effects of Bibenzyl Derivatives from Liverworts, Radula perrottetii

Abstract

The liverwort Radula perrottetii contains various bibenzyl derivatives which are known to possess various biological activities, such as anti-inflammatory effects. Mast cells (MC) play crucial roles in allergic and inflammatory diseases; thus, inhibition of MC activation is pivotal for the treatment of allergic and inflammatory disorders. We investigated the effects of perrottetin D (perD), isolated from Radula perrottetii, and perD diacetate (Ac-perD) on antigen-induced activation of MCs. Bone marrow–derived MCs (BMMCs) were generated from C57BL/6 mice. The degranulation ratio, histamine release, and the interleukin (IL)-4 and leukotriene B₄ productions on antigen-triggered BMMC were investigated. Additionally, the effects of the bibenzyls on binding of IgE to FcεRI were observed by flow cytometry, and signal transduction proteins was examined by Western blot. Furthermore, binding of the bibenzyls to the Fyn kinase domain was calculated. At 10 µM, perD decreased the degranulation ratio (p < 0.01), whereas 10 µM Ac-perD down-regulated IL-4 production (p < 0.05) in addition to decreasing the degranulation ratio (p < 0.01). Both compounds tended to decrease histamine release at a concentration of 10 µM. Although 10 µM perD reduced only Syk phosphorylation, 10 µM Ac-perD diminished phosphorylation of Syk, Gab2, PLC-γ, and p38. PerD appeared to selectively bind Fyn, whereas Ac-perD appeared to act as a weak but broad-spectrum inhibitor of kinases, including Fyn. In conclusion, perD and Ac-perD suppressed the phosphorylation of signal transduction molecules downstream of the FcεRI and consequently inhibited degranulation, and/or IL-4 production. These may be beneficial potential lead compounds for the development of novel anti-allergic and anti-inflammatory drugs.

Key words

liverworts - Radula perrottetii - Radulaceae - mast cells - allergy - inflammation

Publication History

Received: 21 July 2021

Accepted after revision: 25 January 2022

Accepted Manuscript online:
26 January 2022

Article published online:
30 March 2022

• References

• 1 Yamada K. A revision of Asian taxa of radula, hepaticae. J Hattori Bot Lab 1979; 45: 201-322
• 2 Asakawa Y, Hashimoto T, Takikawa K, Tori M, Ogawa S. Prenyl bibenzyls from the liverworts Radula perrottetii and Radula complanata. Phytochemistry 1991; 30: 235-251
• 3 Asakawa Y, Toyota M, Takemoto T. Seven new bibenzyls and a dihydrochalcone from Radula variabilis. Phytochemistry 1978; 17: 2005-2010
• 4 Asakawa Y, Kusube E, Takemoto T, Suire C. New bibenzyls from Radula complanata. Phytochemistry 1978; 17: 2115-2117
• 5 Cretton S, Oyarzún A, Righi D, Sahib L, Kaiser M, Christen P, Fajardo V. A new antifungal and antiprotozoal bibenzyl derivative from Gavilea lutea. Nat Prod Res 2018; 32: 695-701
• 6 Asakawa Y, Nagashima F, Ludwiczuk A. Distribution of bibenzyls, bisbibenzyls, and terpenoids in liverwort genus Radula. J Nat Prod 2020; 83: 756-769
• 7 Hlosrichok A, Sumkhemthong S, Sritularak B, Chanvorachote P, Chaotham C. A bibenzyl from Dendrobium ellipsophyllum induces apoptosis in human lung cancer cells. J Nat Med 2018; 72: 615-625
• 8 Taira Z, Takei M, Endo K, Hashimoto T, Sakiya Y, Asakawa Y. Marchantin A trimethyl ether, its molecular structure and tubocurarine-like skeletal muscle relaxation activity. Chem Pharm Bull 1994; 42: 52-56
• 9 Oozeki H, Tajima R, Nihei K. Molecular design of potent tyrosinase inhibitors having the bibenzyl skeleton. Bioorg Med Chem Lett 2008; 18: 5252-5254
• 10 Allegrone G, Pollastro F, Magagnini G, Taglialatela-Scafati O, Seegers J, Koeberle A, Werz O, Appendino G. The bibenzyl canniprene inhibits the production of pro-inflammatory eicosanoids and selectively accumulates in some cannabis sativa strains. J Nat Prod 2017; 80: 731-734
• 11 Méndez-Enríquez E, Hallgren J. Mast cells and their progenitors in allergic asthma. Front Immunol 2019; 10: 821
• 12 Fu S, Ni S, Wang D, Hong T. Coptisine suppresses mast cell degranulation and ovalbumin-induced allergic rhinitis. Molecules 2018; 23: 3039
• 13 Benedé S, Berin MC. Mast cell heterogeneity underlies different manifestations of food allergy in mice. PLoS One 2018; 13: e0190453
• 14 Nunes de Miranda SM, Wilhelm T, Huber M, Zorn CN. Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype. Cell Commun Signal 2016; 14: 12
• 15 Okabe T, Hide M, Hiragun T, Morita E, Koro O, Yamamoto S. Bone marrow derived mast cell acquire responsiveness to substance P with Ca(2+) signals and release of leukotriene B(4) via mitogen-activated protein kinase. J Neuroimmunol 2006; 181: 1-12
• 16 Nam ST, Park YH, Kim HW, Kim HS, Lee D, Lee MB, Kim YM, Choi WS. Suppression of IgE-mediated mast cell activation and mouse anaphylaxis via inhibition of Syk activation by 8-formyl-7-hydroxy-4-methylcoumarin, 4ƒÊ8C. Toxicol Appl Pharmacol 2017; 332: 25-31
• 17 Barbu EA, Zhang J, Siraganian RP. The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells. J Biol Chem 2010; 285: 15761-15768
• 18 Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG. Essential role for Gab2 in the allergic response. Nature 2001; 412: 186-190
• 19 Kim JH, Kim AR, Kim HS, Kim HW, Park YH, You JS, Park YM, Her E, Kim HS, Kim YM, Choi WS. Rhamnus davurica leaf extract inhibits Fyn activation by antigen in mast cells for anti-allergic activity. BMC Complement Altern Med 2015; 15: 80
• 20 Frossi B, Rivera J, Hirsch E, Pucillo C. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol 2007; 178: 2549-2555
• 21 Velez TE, Bryce PJ, Hulse KE. Mast cell interactions and crosstalk in regulating allergic inflammation. Curr Allergy Asthma Rep 2018; 18: 30
• 22 Gaudenzio N, Sibilano R, Marichal T, Starkl P, Reber LL, Cenac N, McNeil BD, Dong X, Hernandez JD, Sagi-Eisenberg R, Hammel I, Roers A, Valitutti S, Tsai M, Espinosa E, Galli SJ. Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest 2016; 126: 3981-3998
• 23 Krajewski D, Kaczenski E, Rovatti J, Polukort S, Thompson C, Dollard C, Ser-Dolansky J, Schneider SS, Kinney SRM, Mathias CB. Epigenetic regulation via altered histone acetylation results in suppression of mast cell function and mast cell-mediated food allergic responses. Front Immunol 2018; 9: 2414
• 24 Elieh Ali Komi D, Wöhrl S, Bielory L. Mast cell biology at molecular level: A comprehensive review. Clin Rev Allergy Immunol 2020; 58: 342-365
• 25 Kinoshita T, Matsubara M, Ishiguro H, Okita K, Tada T. Structure of human Fyn kinase domain complexed with staurosporine. Biochem Biophys Res Commun 2006; 346: 840-844
• 26 Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77: 1033-1079
• 27 Anderson P, Uvnäs B. Selective localization of histamine to electron dense granules in antigen-challenged sensitized rat mast cells and to similar granules isolated from sonicated mast cells. An electron microscope autoradiographic study. Acta Physiol Scand 1975; 94: 63-73
• 28 Draber P, Halova I, Polakovicova I, Kawakami T. Signal transduction and chemotaxis in mast cells. Eur J Pharmacol 2016; 778: 11-23
• 29 Wang X, Guo J, Ning Z, Wu X. Discovery of a natural syk inhibitor from Chinese medicine through a docking-based virtual screening and biological assay study. Molecules 2018; 23: 3114
• 30 Zhang J, Berenstein EH, Evans RL, Siraganian RP. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated 2degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med 1996; 184: 71-79
• 31 Park YH, Kim HW, Kim HS, Nam ST, Lee D, Lee MB, Min KY, Koo J, Kim SJ, Kim YM, Kim HS, Choi WS. An anti-cancer drug candidate CYC116 suppresses type I hypersensitive immune responses through the inhibition of Fyn kinase in mast cells. Biomol Ther (Seoul) 2019; 27: 311-317
• 32 Asakawa Y, Ludwiczuk A, Nagashima F. Chemical Constituents of the Bryophytes. Bio- and Chemical Diversity, Biological Activity, and Chemosystematics. Progress in the Chemistry of Organic Natural Products. Vienna: Springer; 2013
• 33 Razin E, Ihle JN, Seldin D, Mencia-Huerta JM, Katz HR, LeBlanc PA, Hein A, Caulfield JP, Austen KF, Stevens RL. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 1984; 132: 1479-1486
• 34 Mekori YA, Oh CK, Metcalfe DD. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol 1993; 151: 3775-3784
• 35 Fukuishi N, Igawa Y, Kunimi T, Hamano H, Toyota M, Takahashi H, Kenmoku H, Yagi Y, Matsui N, Akagi M. Generation of mast cells from mouse fetus: analysis of differentiation and functionality, and transcriptome profiling using next generation sequencer. PLoS One 2013; 8: 1-12
• 36 Fukuishi N, Murakami S, Ohno A, Yamanaka N, Matsui N, Fukutsuji K, Yamada S, Itoh K, Akagi M. Does beta-hexosaminidase function only as a degranulation indicator in mast cells? The primary role of beta-hexosaminidase in mast cell granules. J Immunol 2014; 193: 1886-1894
• 37 Galatowicz G, Ajayi Y, Stern ME, Calder VL. Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin Exp Allergy 2007; 37: 1648-1656
• 38 Akagi M, Mio M, Miyoshi K, Tasaka K. Antiallergic effects of terfenadine on immediate type. Immunopharmacol immunotoxicol hypersensitivity reactions. Immunopharmacol Immunotoxicol 1987; 9: 257-279
• 39 Kim MJ, Park HR, Shin TY, Kim SH. Diospyros kaki calyx inhibits immediate-type hypersensitivity via the reduction of mast cell activation. Pharm Biol 2017; 55: 1946-1953
• 40 Takasugi M, Muta E, Yamada K, Arai H. A new method to evaluate anti-allergic effect of food component by measuring leukotriene B4 from a mouse mast cell line. Cytotechnology 2018; 70: 177-184
• 41 Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997; 267: 727-748
• 42 Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res 2018; 46: W296-W303
• 43 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich AV, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, Montgomery jr. JA, Peralta JE, Ogliaro F, Bearpark MJ, Heyd JJ, Brothers EN, Kudin KN, Staroverov VN, Keith TA, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JW, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ. Gaussian 16 Revision A.03. Wallingford, CT: Gaussian Inc.; 2016